Cargando…

Health-related quality of life in children with chronic immune thrombocytopenia in China

BACKGROUND: The concept of health-related quality of life (HRQoL) was brought up decades ago and has been well utilized in many different areas. Regarding immune thrombocytopenia (ITP) management, much work has been done to emphasize the necessity of taking HRQoL into consideration. However, data on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Heng, Wang, Li, Quan, Meijie, Huang, Jie, Wu, Peng, Lu, Qin, Fang, Yongjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792088/ https://www.ncbi.nlm.nih.gov/pubmed/26979950 http://dx.doi.org/10.1186/s12955-016-0445-3

Ejemplares similares

Health-related quality of life in children with haemophilia in China: a 4-year follow-up prospective cohort study
por: Zhang, Heng, et al.
Publicado: (2019)

Efficacy and quality of life of Romiplostim in adults and children with immune thrombocytopenia: A review
por: He, Xin, et al.
Publicado: (2022)

Immune thrombocytopenia: improving quality of life and patient outcomes
por: Trotter, Patrick, et al.
Publicado: (2018)

Reliability and validity of the Amharic version of immune thrombocytopenia life quality index tool for assessment of the health-related quality of life in Ethiopian patients of immune thrombocytopenia: Cross-sectional study
por: Beyene, Dessale Abate, et al.
Publicado: (2023)

Elevated NKT cell levels in adults with severe chronic immune thrombocytopenia
por: XU, RUILONG, et al.
Publicado: (2014)

PB2685: QUALITY OF LIFE IN INDIAN ADULTS WITH IMMUNE THROMBOCYTOPENIA
por: Bhat, Vivek, et al.
Publicado: (2023)

Spotlight on eltrombopag in the treatment of children with chronic immune thrombocytopenia
por: Lambert, Michele P
Publicado: (2016)

PB2623: AVATROMBOPAG FOR THE TREATMENT OF CHILDREN WITH PERSISTENT AND CHRONIC IMMUNE THROMBOCYTOPENIA
por: An, Qi, et al.
Publicado: (2023)

Avatrombopag for adult chronic primary immune thrombocytopenia: a randomized phase 3 trial in China
por: Mei, Heng, et al.
Publicado: (2023)

Risk Factors and Psychological Analysis of Chronic Immune Thrombocytopenia in Children
por: Sun, Ying, et al.
Publicado: (2020)

Acute on Chronic Immune Thrombocytopenia as a Cause of Thrombocytopenia in Sepsis
por: Kudaravalli, Pujitha, et al.
Publicado: (2020)

Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease
por: Cheloff, Abraham Z, et al.
Publicado: (2019)

Changes in health‐related quality of life with long‐term eltrombopag treatment in adults with persistent/chronic immune thrombocytopenia: Findings from the EXTEND study
por: Khelif, Abderrahim, et al.
Publicado: (2018)

Immune Checkpoint-Related Gene Polymorphisms Are Associated With Primary Immune Thrombocytopenia
por: Wang, Shuwen, et al.
Publicado: (2021)

Immune thrombocytopenia (ITP) World Impact Survey (I‐WISh): Impact of ITP on health‐related quality of life
por: Cooper, Nichola, et al.
Publicado: (2020)

Lifestyle-related behaviors and health-related quality of life among children and adolescents in China
por: Qin, Zhenzhen, et al.
Publicado: (2021)

Efficacy and safety of eltrombopag in the treatment of severe chronic immune thrombocytopenia in children of China: A single-center observational study
por: Cheng, Xiaoling, et al.
Publicado: (2019)

Helicobacter pylori Infection and Chronic Immune Thrombocytopenia
por: Takeuchi, Hiroaki, et al.
Publicado: (2022)

Efficient adaptation of high‐quality international guidelines for Chinese children with primary immune thrombocytopenia
por: Liu, Yali, et al.
Publicado: (2022)

Chronic Refractory Immune Thrombocytopenia Is Associated With Variants in Immune Genes
por: Zhao, Shasha, et al.
Publicado: (2021)

T cell immune abnormalities in immune thrombocytopenia
por: Ji, Xuebin, et al.
Publicado: (2014)

Regulatory T-lymphocyte subsets in children with chronic immune thrombocytopenia after high-dose of dexamethasone
por: Elsayh, Khalid Ibrahim, et al.
Publicado: (2022)

AZD-1222/tozinameran: Immune thrombocytopenia and exacerbation of pre-existing chronic immune thrombocytopenia: 4 case reports
Publicado: (2022)

Gut microbiota alterations in children and their relationship with primary immune thrombocytopenia
por: Li, Xiangyu, et al.
Publicado: (2023)

Immune thrombocytopenia
Publicado: (2011)

A Saudi Child With Chronic Immune Thrombocytopenia and Vitiligo
por: Alhebshi, Abdulqader, et al.
Publicado: (2020)

Platelet size for distinguishing between inherited thrombocytopenias and immune thrombocytopenia: a multicentric, real life study
por: Noris, Patrizia, et al.
Publicado: (2013)

Inflammation-Related Gene Polymorphisms Associated With Primary Immune Thrombocytopenia
por: Li, Ju, et al.
Publicado: (2017)

Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia
por: Viana, Ricardo, et al.
Publicado: (2021)

Health-related quality of life of children with Williams syndrome and caregivers in China
por: Chen, Weijun, et al.
Publicado: (2023)

Rituximab for Children with Immune Thrombocytopenia: A Systematic Review
por: Liang, Yi, et al.
Publicado: (2012)

Immune thrombocytopenia: serum cytokine levels in children and adults
por: Čulić, Srđana, et al.
Publicado: (2013)

Covid-19 and Children with Immune Thrombocytopenia: Emerging Issues
por: Lassandro, Giuseppe, et al.
Publicado: (2020)

Response to rituximab in children and adults with immune thrombocytopenia (ITP)
por: Harris, Emily M., et al.
Publicado: (2021)

Association of Immune Thrombocytopenia and Inflammatory Bowel Disease in Children
por: Guarina, Angela, et al.
Publicado: (2021)

Long-Term Use of the Thrombopoietin-Mimetic Romiplostim in Children With Severe Chronic Immune Thrombocytopenia (ITP)
por: Bussel, James B, et al.
Publicado: (2015)

High Remission Rate of Chronic Immune Thrombocytopenia in Children: Result of 20-Year Follow-Up
por: Kim, Chae Young, et al.
Publicado: (2016)

Efficacy and safety of thrombopoietin receptor agonists in children with chronic immune thrombocytopenia: a meta-analysis
por: Guo, Jian-Chun, et al.
Publicado: (2017)

Spotlight on romiplostim in the treatment of children with chronic immune thrombocytopenia: design, development, and potential place in therapy
por: Buchbinder, David, et al.
Publicado: (2017)

Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopenia
por: Tarantino, Michael D., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_aar4tvea2sr58kitr2l6emisnd